Physics And Chemistry Basis Of Biotechnology - De Cuyper - tiera.ru
Physics And Chemistry Basis Of Biotechnology - De Cuyper - tiera.ru
Physics And Chemistry Basis Of Biotechnology - De Cuyper - tiera.ru
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>De</strong>ndrimers: Chemical principles and biotechnology applications<br />
lysine core of seven lysine units and eight arms of peptides that contain antigenic<br />
epitopes. The overall st<strong>ru</strong>cture of the MAP system is a polymer with a high density of<br />
surface peptide antigens and a molecular weight greater than 10 K [90]. The almost<br />
mutually exclusive desire to attach a large number of d<strong>ru</strong>g molecules to an antibody<br />
while still retaining maximal antibody immunoreactivity may be overcome by<br />
dendrimers which act as intermediate linkers between the d<strong>ru</strong>gs (capable of covalent<br />
attachment to the dendrimer) and the antibody (which binds to the dendrimer by only<br />
one modified site on the antibody).<br />
A MAP dendrimer with a lipophilic surface has been synthesised for possible d<strong>ru</strong>g<br />
delivery. These lipoamino acids while lipophilic also retain the solvation properties of<br />
amino acids and peptides [91]. MAP dendrimers are peptide dendrimers which amplify<br />
peptide immunogenicity. Unlike most vaccines, MAPS can be stored or shipped as<br />
powders. There is an excellent review on MAPS [92]. They have been used in-vitro as<br />
immunogens, vaccines, immunodiagnostics, serodiagnostics, ligands, inhibitors,<br />
artificial proteins, epitope mapping, affinity purification, presentation of T-cell epitopes<br />
and intracellular delivery. The synthesis of MAP dendrimers has been improved by the<br />
use of a N-acetylation capping step which allows the direct (stepwise) synthesis and<br />
purification of MAPS. The automated peptide synthesiser was programmed to provide<br />
a N-acetylation capping reaction following each amino acid coupling reaction thus<br />
serving as a protecting group for further reaction with unwanted amino acids in the<br />
c<strong>ru</strong>de mixture [93].<br />
3.4. BORON NEUTRON CAPTURE THERAPY<br />
Boron neutron capture therapy is based on the nuclear reaction that occurs when a<br />
stable B-10 isotope is irradiated with low-energy neutrons to yield high LET radiation<br />
consisting of alpha particles and recoiling Li-7 which are energetic and cytotoxic [94].<br />
To deliver the approximately 10 9 number of B-10 atoms needed to effectively eradicate<br />
a tumour cell, dendrimers have been conjugated with a polyhedral borane and<br />
subsequently attached to a monoclonal antibody. The number of boron atoms range<br />
from 250 to 1000 per dendrimer molecule. Unfortunately, in-vivo studies with mice<br />
revealed hepatic and splenic uptake over tumour localisation. Instead of attaching the<br />
polyhedral borane to the periphery or surface of the dendrimer, the borane cluster has<br />
been incorporated into the interior of the dendrimer [95]. <strong>De</strong>caborane was reacted with<br />
the alkyne functionality located in the interior of the dendrimer to give 0-carboranes.<br />
The incorporation into the interior of the dendrimer increased their aqueous solubility.<br />
An interesting application of boronated dendrimers is in electron spectroscopic<br />
imaging-based immunocytochemistry [9G]. The dendrimers contain a boron cluster on<br />
one side of the dendrimer and an antibody fragment on the other side. These antibodydendrimer-boranes<br />
were used to allow the visual detection of BSA in epithelial cells of<br />
ileum which had been internalised by endocytotic vesicles of ileal enterocytes in newborn<br />
piglets after administration of BSA. As determined by electron spectroscopic<br />
imaging of boron, a G4 starburst dendrimer bearing an epidermal growth factor was<br />
bound to the cell membrane and endocytosed in-vitro of the human malignant glioma<br />
U-343MG cell line expressing EGF receptors [97].<br />
57